---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-023291"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2023-02-17T23:59:59+00:00"
generated_at: "2026-06-19T08:10:39.711265+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Abbott reduces board size from 13 to 12, effective April 28, 2023

## Summary
- Board approved amendment to Article III, Section 2 of by-laws on Feb 17, 2023.
- Board size reduced from 13 to 12 directors, effective April 28, 2023.
- Amended by-laws filed as Exhibit 3.1 to the Form 8-K.

## SEC filing metadata
- accession: 0001104659-23-023291
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2023-02-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465923023291/0001104659-23-023291-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465923023291/tm236955d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-023291
- JSON: https://secwatch.observer/filing/0001104659-23-023291.json
- Plain text: https://secwatch.observer/filing/0001104659-23-023291.txt

## Key facts
- Governance Changes
  ABBOTT LABORATORIES: Board of Directors size changed from 13 to 12 persons, effective April 28, 2023 (effective 2023-04-28).
  - Change: bylaw amendment
  - Effective: 2023-04-28
  source text: Abbott’s Board of Directors amended the first sentence of Article III, Section 2 of Abbott’s by-laws to provide that Abbott’s Board of Directors shall consist of twelve persons, effective April 28, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800/000110465923023291/0001104659-23-023291-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.